HyperRHO (Anti-D) 1500 IU Single Dose - Human Anti-D Immunoglobulin. Indications: Hemolytic disease of the newborn (HDN). Full Description
Indications: Hemolytic disease of the newborn (HDN), which is a blood disorder that occurs when the blood types of a mother and baby are incompatible (the mother’s blood is Rh negative and the baby’s is Rh positive).
HyperRHO recommended to be given in week 28 and within 72 hours after delivery.
HyperRHO Properties:
- Pink cover to avoid contaminants transmission between nurse and patient.
- Prefilled syringe ready to be administered.
- (4) steps of virus removal and inactivation process.
HyperRHO should be Store at 2–8°C. Do not freeze.
